Trademark: OMBLASTYS (OMBURTAMAB)
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
OMBLASTYS (OMBURTAMAB)
Click here to search for trademarks similar to OMBLASTYS (OMBURTAMAB)
Proof of use for OMBLASTYS (OMBURTAMAB)
We do not have any records of a proof of use for OMBLASTYS (OMBURTAMAB) at this moment.
Possible trademark infringements of OMBLASTYS (OMBURTAMAB)
Basic Information about OMBLASTYS (OMBURTAMAB)
- Serial Number
- 88886712
- Filing Date
- 24 Apr 2020
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of OMBLASTYS (OMBURTAMAB) on the blockchain with WikiTrademarks.io.
- First use of OMBLASTYS (OMBURTAMAB) anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
- First use of OMBLASTYS (OMBURTAMAB) anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 042
- US Codes
- 100; 101
Who owns OMBLASTYS (OMBURTAMAB)?
1. Y-mAbs Therapeutics, Inc New York NY
Correspondent
- Andrew N. Spivak
- MOSAIC LEGAL GROUP, PLLC
- 5185 MACARTHUR BOULEVARD, NW, SUITE 350
- WASHINGTON, DC 20016-3341
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io